Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
- 1 June 1999
- journal article
- Published by Elsevier in Life Sciences
- Vol. 65 (3) , 327-336
- https://doi.org/10.1016/s0024-3205(99)00251-9
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brainLife Sciences, 1997
- Involvement of GABAB receptors in the motor inhibition produced by agonists of brain cannabinoid receptorsBehavioural Pharmacology, 1996
- Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1, receptor ligandLife Sciences, 1996
- Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal functionBrain Research, 1995
- The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neuronsLife Sciences, 1995
- Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)International Clinical Psychopharmacology, 1994
- γ-Aminobutyric acid (GABAB) receptor-mediated inhibition of tyrosine hydroxylase activity in the striatum of ratNeuropharmacology, 1991
- The cannabinoid receptor: biochemical, anatomical and behavioral characterizationTrends in Neurosciences, 1990
- Effects of Repeated Administration of Estradiol Benzoate on Tubero‐Infundibular GABAergic Activity in Male RatsJournal of Neurochemistry, 1985